[HTML][HTML] Understanding COVID-19-associated coagulopathy
EM Conway, N Mackman, RQ Warren… - Nature Reviews …, 2022 - nature.com
Abstract COVID-19-associated coagulopathy (CAC) is a life-threatening complication of
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …
SARS-CoV-2 infection. However, the underlying cellular and molecular mechanisms driving …
Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis
A Porfidia, E Valeriani, R Pola, E Porreca… - Thrombosis research, 2020 - Elsevier
Background Venous thromboembolism (VTE) may complicate the course of Coronavirus
Disease 2019 (COVID-19). Objectives To evaluate the incidence of VTE in patients with …
Disease 2019 (COVID-19). Objectives To evaluate the incidence of VTE in patients with …
Coagulopathy in COVID-19: Focus on vascular thrombotic events
W Shi, J Lv, L Lin - Journal of molecular and cellular cardiology, 2020 - Elsevier
SARS-CoV-2 causes a phenotype of pneumonia with diverse manifestation, which is termed
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …
as coronavirus disease 2019 (COVID-19). An impressive high transmission rate allows …
[HTML][HTML] Anticoagulant treatment in COVID-19: a narrative review
V Carfora, G Spiniello, R Ricciolino, M Di Mauro… - Journal of thrombosis …, 2021 - Springer
Abstract The actual Coronavirus Disease (COVID 19) pandemic is due to Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the coronavirus family …
respiratory syndrome coronavirus 2 (SARS-CoV-2), a member of the coronavirus family …
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management
ABSTRACT Introduction SARS-CoV-2, the causative agent of COVID-19, attacks the
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …
immune system causing an exaggerated and uncontrolled release of pro-inflammatory …
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
Abstract The 2019 coronavirus disease (COVID-19) presents with a large variety of clinical
manifestations ranging from asymptomatic carrier state to severe respiratory distress …
manifestations ranging from asymptomatic carrier state to severe respiratory distress …
Predictors and mortality risk of venous thromboembolism in patients with COVID-19: systematic review and meta-analysis of observational studies
G Agarwal, A Hajra, S Chakraborty… - Therapeutic …, 2022 - journals.sagepub.com
Introduction: Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection resulting in COVID-19 disease is associated with widespread inflammation and a …
infection resulting in COVID-19 disease is associated with widespread inflammation and a …
COVID‐19, thromboembolic risk, and Virchow's triad: lesson from the past
JL Mehta, G Calcaterra, PP Bassareo - Clinical cardiology, 2020 - Wiley Online Library
Abstract COronavirus Infectious Disease which started in 2019 (COVID‐19) usually presents
with the signs and symptoms of pneumonia. However, a growing number of recent reports …
with the signs and symptoms of pneumonia. However, a growing number of recent reports …
[HTML][HTML] Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic
B Marchandot, A Trimaille, A Curtiaud… - Journal of Thrombosis …, 2020 - Springer
A common and potent consideration has recently entered the landscape of the novel
coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has …
coronavirus disease of 2019 (COVID-19): venous thromboembolism (VTE). COVID-19 has …
COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
Abstract COVID-19-associated coagulopathy (CAC) is a feature of COVID-19 that can lead
to various thrombotic complications and death. In this review, we briefly highlight possible …
to various thrombotic complications and death. In this review, we briefly highlight possible …